Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives. [electronic resource]

By: Contributor(s): Publication details: OncoTargets and therapy 2019Description: 4567-4575 p. digitalISSN:
  • 1178-6930
Online resources: In: OncoTargets and therapy vol. 12
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.